chronic lymphocytic leukemia, hairy cell leukemia and related diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Untreated, B-cell chronic lymphocytic leukemia, B-cell prolymphocytic leukemia, hairy cell leukemia,and other indolent B-cell leukemias fulfilling (1)absolute iymphocyte count of 5000/ul or more in the peripheral blood or (2)abnormal lymphocytes of 20% or more in the peripheral blood.
Exclusion criteria
Exclusion criteria: Nothing special.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The incidence of somatic hypermutation of immunoglobulin heavy chain gene of each group in Japanese patients with indolent B-cell neoplasms | — |
Secondary
| Measure | Time frame |
|---|---|
| The overall survival rate of mutated and un-mutated subgroups, overall survival period and survival time from treatment initiation in Japanese patients with indolent B-cell neoplasms | — |
Countries
Japan
Contacts
Niigata University Graduate School of Medical & Dental Sciences Division of Hematology